Gene expression profiling of day 7 erythroblasts from RARS before and after treatment with G-CSF
Príomhchruthaitheoirí: | Nikpour, M, Pellagatti, A, Jadersten, M, Forsblom, A, Wainscoat, J, Boultwood, J, Hellstroem-Lindberg, E |
---|---|
Formáid: | Conference item |
Foilsithe / Cruthaithe: |
2007
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets
de réir: Nikpour, M, et al.
Foilsithe / Cruthaithe: (2009) -
Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G-CSF.
de réir: Nikpour, M, et al.
Foilsithe / Cruthaithe: (2010) -
YI1 Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets
de réir: Nikpour, M, et al.
Foilsithe / Cruthaithe: (2009) -
NEW INSIGHTS INTO THE BIOLOGY OF REFRACTORY ANEMIA WITH RING SIDEROBLASTS (RARS) AND IDENTIFICATION OF ERYTHROID G-CSF TARGETS BY GENE EXPRESSION PROFILING
de réir: Nikpour, M, et al.
Foilsithe / Cruthaithe: (2009) -
Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
de réir: Jadersten, M, et al.
Foilsithe / Cruthaithe: (2005)